Search filters

List of works by Cristina Nieto-Jiménez

Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer

scientific article published on 30 August 2019

BET inhibitors as novel therapeutic agents in breast cancer.

scientific article published on August 2017

DNA-damage related genes and clinical outcome in hormone receptor positive breast cancer

scientific article published on 28 July 2016

Evaluation of transcriptionally regulated genes identifies NCOR1 in hormone receptor negative breast tumors and lung adenocarcinomas as a potential tumor suppressor gene

scientific article published in PLoS ONE

Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome

scientific article published on 03 July 2019

Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors

article

In silico analyses identify gene-sets, associated with clinical outcome in ovarian cancer: role of mitotic kinases.

scientific article published on 16 March 2016

Mapping Bromodomains in breast cancer and association with clinical outcome

scientific article published on 05 April 2019

Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors.

scientific article published on March 2017

Neutrophils in cancer: prognostic role and therapeutic strategies.

scientific article published on 15 August 2017

Poly(Cyclohexene Phthalate) Nanoparticles for Controlled Dasatinib Delivery in Breast Cancer Therapy

scientific article published on 27 August 2019

Screening and Preliminary Biochemical and Biological Studies of [RuCl(p-cymene)(N,N-bis(diphenylphosphino)-isopropylamine)][BF4] in Breast Cancer Models

scientific article published on 01 August 2019

Synthetic lethality interaction between Aurora kinases and CHEK1 inhibitors in ovarian cancer.

scientific article published on 28 August 2017

Targeting basal-like breast tumors with bromodomain and extraterminal domain (BET) and polo-like kinase inhibitors

scientific article published on 3 January 2017

Trastuzumab-Targeted Biodegradable Nanoparticles for Enhanced Delivery of Dasatinib in HER2+ Metastasic Breast Cancer

scientific article published on 16 December 2019